Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction

TARTAN, Zeynep; OZER, Nihat; UYAREL, Huseyin; AKGUL, Ozgur; GUL, Mehmet; Cetin, MUSTAFA; KASIKCIOGLU, Hulya; CAM, Nese

doi:10.1016/j.numecd.2007.02.015

Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction

Atıf İçin Kopyala

TARTAN Z., OZER N., UYAREL H., AKGUL O., GUL M., Cetin M., ...Daha Fazla

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, cilt.18, sa.6, ss.441-447, 2008 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 18 Sayı: 6
Basım Tarihi: 2008
Doi Numarası: 10.1016/j.numecd.2007.02.015
Dergi Adı: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.441-447
Anahtar Kelimeler: metabolic syndrome, no-reflow phenomenon, ST-segment, resolution, primary coronary intervention, CORONARY-ARTERY OCCLUSION, INSULIN-RESISTANCE, REPERFUSION, RESOLUTION, FLOW, ANGIOPLASTY, DYSFUNCTION, PERFUSION, PLATELET, ABNORMALITIES
Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

background and aim: The purpose of this study was to evaluate both the predictive value of metabolic syndrome (MS) on no-reflow phenomenon and 30-day clinical outcomes on patients undergoing primary percutaneous coronary intervention (PCI) for acute ST-elevation myocardial infaction (STEMI).